Method for synthesizing avibactam intermediate compound
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHENGDU CLIMB PHARMA TECH
- Publication Date
- 2019-11-12
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine preparation, and in particular relates to a synthesis method of an avibactam intermediate compound. Background technique
[0002] Avibactam is a novel β-lactamase inhibitor that can reversibly bind to the enzyme covalently. As a new type of enzyme inhibitor, avibactam has significant and extensive enzyme inhibitory effects, can restore or enhance the activity of combined antibiotics, and is of great significance to the treatment of clinical bacterial infections, especially drug-resistant bacterial infections.
[0003] Compound E1 is a key intermediate for the synthesis of avibactam, and its structural formula is:
[0004]
[0005] The synthetic method for preparing E1 in the prior art has more or less defects. For example, the synthetic route described in the patent document WO2013149136 is:
[0006]
[0007] This route requires the use of metal iridium [Ir(COD)Cl] 2 catalysts resulting in high cos...